Wambeke David J.
Chief Business Officer
Wambeke David J. has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Sep 8, 2026.
On the most recent filing, Wambeke David J. is listed as Chief Business Officer at NEUROONE MEDICAL TECHNOLOGIES Corp. Inside the rolling window, Wambeke David J. reported 2 open-market purchases totaling $737K in NMTC and no open-market sales. The largest disclosed transaction in the window is a purchase of 1,000,000 NMTC shares on Mar 1, 2026, worth $670K.
Companies traded
Other insiders at NMTC
Insider Buying
$737K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Wambeke David J. made?
Wambeke David J. has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Wambeke David J. trade?
Wambeke David J. has filed SEC Form 4 disclosures for 1 company, including NMTC.
When was Wambeke David J.'s most recent SEC Form 4 filing?
Wambeke David J.'s most recent SEC Form 4 filing on Tracefour is dated Sep 8, 2026.
What is Wambeke David J.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Wambeke David J. is listed as Chief Business Officer.
What is Wambeke David J.'s total buy and sell value in the current window?
Inside the rolling retention window, Wambeke David J. bought $737K and sold $0 based on SEC Form 4 filings.
What was Wambeke David J.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,000,000 NMTC shares on 2026-03-01, worth $670K, per SEC Form 4 filings.